Testimonials
Martin Rothman MD “I’ve carried out some direct stenting with the MGuard over some very obvious scary clots and we’ve seen no vessel loss downstream in those patients. Enzyme rises have been consistent with successful treatment of an early MI as if there was no clot”
Eberhard Grube MD “Based on the animal studies and the interim results in the clinical trial, we are confident that the MGuard stent is safe and effective”
Ricardo Costa MD “The MGuard device shows excellent performance in highly complex lesions. In our preliminary experience there was an absence of angiographic and procedural complications and no events after 30 days”
Gregory Pavlides MD “The first thing that came into our mind when we first saw this stent is that it is a wonderf ul device to improve embolic protection for PCI, other embolic situations, acute MI or SVG.”
Antonio Colombo MD “This is a new concept in coronary stenting which may profoundly impact in the treatment of some types of lesions and patients."
“This is a simple and practical approach to treat thrombus containing lesions. Based on my experience I was able to treat very complex lesions without the need of distal protective devices”
|
